<DOC>
	<DOC>NCT01073826</DOC>
	<brief_summary>The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.</brief_summary>
	<brief_title>Role of Interleukin-6 in Exercise</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Inclusion criteria: Obesity group: BMI 3040 kg/m2, fasting plasma glucose &lt;6.4 mmol/l. Diabetes group: Type 2 diabetes according to American Diabetes Association criteria Exclusion criteria: Antidiabetic drug other than metformin Diabetes duration of more than 5 years Inflammatory diseases Current infection Liver disease (transaminases &gt;2x upper normal range) kidney disease (creatinine &gt;1.5 mg/dl for men and 1.4 mg/dl for women) pregnancy or breastfeeding, women of child bearing potential not using an acceptable form of contraception immunosuppressive disease corticosteroid use regular nonsteroidal antinflammatory drug usage history of carcinoma history of tuberculosis anemia, bleeding disorders obstructive pulmonary disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>